Pöhlmann, J., Montagnoli, R., Lastoria, G., Parekh, W., Markert, M., & Hunt, B. (2019). Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus iGlarLixi In Italy. Clinicoecon Outcomes Res.
Citação norma ChicagoPöhlmann, Johannes, Roberta Montagnoli, Giusi Lastoria, Witesh Parekh, Marie Markert, and Barnaby Hunt. "Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus IGlarLixi In Italy." Clinicoecon Outcomes Res 2019.
MLA citiranjePöhlmann, Johannes, et al. "Value For Money In The Treatment Of Patients With Type 2 Diabetes Mellitus: Assessing The Long-Term Cost-Effectiveness Of IDegLira Versus IGlarLixi In Italy." Clinicoecon Outcomes Res 2019.